Assets in USD of BioLineRx Ltd. from Q4 2016 to Q4 2024

Taxonomy & unit
ifrs-full: USD
Summary
BioLineRx Ltd. quarterly Assets history and change rate from Q4 2016 to Q4 2024.
  • BioLineRx Ltd. Assets for the quarter ending 31 Dec 2024 was $38.9M, a 39.1% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

BioLineRx Ltd. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $38.9M -$25M -39.1% 31 Dec 2024 20-F 31 Mar 2025
Q2 2024 $64.6M +$5.66M +9.6% 30 Jun 2024 6-K 15 Aug 2024
Q4 2023 $63.9M -$12.5M -16.3% 31 Dec 2023 20-F 31 Mar 2025
Q2 2023 $58.9M -$8.9M -13.1% 30 Jun 2023 6-K 30 Aug 2023
Q4 2022 $76.4M -$5.01M -6.15% 31 Dec 2022 20-F/A 26 Mar 2024
Q2 2022 $67.8M -$23.5M -25.7% 30 Jun 2022 6-K 16 Aug 2022
Q4 2021 $81.4M +$34.1M +72.1% 31 Dec 2021 20-F 22 Mar 2023
Q2 2021 $91.3M +$38.3M +72.4% 30 Jun 2021 6-K 18 Aug 2021
Q4 2020 $47.3M -$6.28M -11.7% 31 Dec 2020 20-F 16 Mar 2022
Q2 2020 $53M -$8.97M -14.5% 30 Jun 2020 6-K 06 Aug 2020
Q4 2019 $53.6M -$2.67M -4.74% 31 Dec 2019 20-F 23 Feb 2021
Q2 2019 $62M +$9.75M +18.7% 30 Jun 2019 6-K 06 Aug 2019
Q4 2018 $56.2M -$4.73M -7.76% 31 Dec 2018 20-F 12 Mar 2020
Q2 2018 $52.2M 30 Jun 2018 6-K 13 Aug 2018
Q4 2017 $61M +$22M +56.6% 31 Dec 2017 20-F 28 Mar 2019
Q4 2016 $38.9M 31 Dec 2016 20-F 06 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.